BP Koirala Memorial Cancer Hospital in Chitwan has introduced a new service for detecting different types of blood cancer.

The flow cytometry-based assay measures the expression of the protein FcyR11a as a biomarker for cardiovascular risk.

"MRD testing has revolutionized our approach to multiple myeloma, allowing us to detect even the smallest traces of cancer ...

Spin-out ChromaTwist has won a prestigious Innovate UK Smart grant to co-fund a £0.5m project.  The funding from Innovate UK, the UK’s innovation agency, covers 70% of the cost of a project that will ...

A new phase 1 trial demonstrates the safety and effectiveness of personalized neoantigen DNA vaccines, showing promising ...

bioAffinity Technologies’ (Nasdaq: BIAF; BIAFW) Vice President of Diagnostics, Jennifer Rebeles, Ph.D., was part of a panel of worldwide experts that published the peer-reviewed paper ...

This basic research study presents useful data concerning the menstrual fluid composition and its potential for endometriosis biomarker research. However, despite solid bioinformatics analyses, the ...

“Involvement of Type 1 Invariant Natural Killer T Cells in Driving Lung Fibrosis,” outlining flow cytometry and quantitative PCR analysis in bronchoalveolar lavage fluid from IPF patients and healthy ...

flow cytometry, microarrays, in situ hybridization, and other technologies. Sequencing technology holds the largest market ...

Polymerase chain reaction (PCR) tests are more sensitive, but still require blood sampling. The new platform – Cytophone – ...